Research and Training to create assets in the form of new companies to develop a new model to generate innovative therapies

研究和培训以新公司的形式创建资产，开发新模式以产生创新疗法

• 批准号: MR/W004291/1
• 负责人: Anguraj Sadanandam
• 金额: $ 10.77万
• 依托单位: Institute of Cancer Research
• 依托单位国家: 英国
• 项目类别: Research Grant
• 财政年份: 2021
• 资助国家: 英国
• 起止时间: 2021 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=MR%2FW004291%2F1
• 关键词: Research; Training; create; assets; form

Cancer Research UK has partnered with Deep Science Ventures to create an opportunity for early career stage researchers to build ventures that target the complexity of biology. This partnership brings together the world's largest independent funder of cancer research with the unique venture design process of Deep Science Ventures to create a programme that is exhaustive in the search for the best approach from both technical and commercial perspectives, and positioned for new venture growth from day one. Their aim is to identify and bring together entrepreneurial scientists, academic advisors and investors to design and build new companies in oncology.In this project, the research goal is to develop therapies by leveraging the wealth of data of this new era to identify ways to kill cancer cells so that can escape from treatments. My role will be to start as a Founder Analyst within DeepScienceVentures under their unique framework for venture creation. It's a part-time role working mainly involving research. In order to make this research successful, I will apply my skills sets of machine learning/artificial intelligence, understanding heterogeneity, developing patient-based biomarkers and hands-on experience in preclinical trials. This also provides opportunity to get trained in market analysis, and customer development together with the DSV team before incorporating our own start-up.

英国癌症研究中心与Deep Science Ventures合作，为早期职业阶段的研究人员创造机会，建立针对生物学复杂性的企业。这种合作关系将世界上最大的癌症研究独立资助者与Deep Science Ventures独特的风险投资设计流程结合在一起，以创建一个从技术和商业角度寻找最佳方法的计划，并从第一天起就定位于新的风险投资增长。他们的目标是识别并汇集创业科学家，学术顾问和投资者，设计和建立肿瘤学新公司。在这个项目中，研究目标是通过利用这个新时代的丰富数据来开发治疗方法，以确定杀死癌细胞的方法，从而可以逃避治疗。我的角色将是作为DeepScienceVentures的创始人分析师，在他们独特的风险投资框架下开始。这是一个兼职的角色，主要从事研究工作。为了使这项研究取得成功，我将运用我的机器学习/人工智能技能，了解异质性，开发基于患者的生物标志物和临床前试验的实践经验。这也提供了机会，以获得市场分析培训，并与DSV团队一起客户开发之前，纳入我们自己的启动。